Press Releases

12345678910
Greg Brown, Chairman and CEO, Motorola Solutions to Participate in Raymond James Institutional Investors Conference
Motorola Solutions (NYSE: MSI), a global leader in public safety and enterprise security, today announced that Greg Brown, Chairman and CEO, will participate at the upcoming Raymond James Institutional Investors Conference on Monday, March 2, 2026, at 9:50 a.m. EST.
By Motorola Solutions · Via Business Wire · February 23, 2026
Genworth Financial Announces Fourth Quarter 2025 Results
Genworth Financial, Inc. (NYSE: GNW) today reported results for the quarter ended December 31, 2025.
By Genworth Financial, Inc. · Via Business Wire · February 23, 2026
Offerpad Announces Q4 and FY 2025 Financial Results
Offerpad (NYSE: OPAD), a real estate solutions company built to provide sellers and partners with multiple ways to transact, today reported financial results for the fourth quarter ended December 31, 2025.
By Offerpad · Via Business Wire · February 23, 2026
General Fusion to Highlight Commercialization Path and Capital Markets Strategy at Upcoming Global Fusion Industry and Investor Conferences
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- General Fusion Inc. (“General Fusion” or the “Company”), a leader in the global race to make commercial fusion energy a reality, today announced its participation in several prominent global conferences throughout February and March. Company executives will highlight General Fusion’s commercialization strategy, capital markets path, and the role of fusion in the future clean energy mix. The Company recently announced its plans to go public through a business combination (the transactions contemplated by the business combination, collectively, the “Proposed Business Combination”) with Spring Valley Acquisition Corp. III (NASDAQ: SVAC) (“SVAC”). 
By General Fusion · Via GlobeNewswire · February 23, 2026
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in March:
By Relay Therapeutics, Inc. · Via GlobeNewswire · February 23, 2026
Great Lakes Reports Fourth Quarter and Full Year 2025 Results and the Signing of Two International Offshore Energy Contracts
Record full year revenue of $888.3 millionFull year net income of $73.5 million (Adjusted net income of $81.6 million)Record full year Adjusted EBITDA of $171.3 million
Phillips Edison & Company to Present at Citi’s 2026 Global Property CEO Conference
CINCINNATI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or “the Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced that the Company will participate in a roundtable presentation at Citi’s 2026 Global Property CEO Conference on Monday, March 2, 2026 at 8:10 a.m. ET.
By Phillips Edison & Company, Inc. · Via GlobeNewswire · February 23, 2026
ROC Announces Closing of Upsized Initial Public Offering
DENVER, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Rank One Computing Corporation d/b/a ROC, (Nasdaq: ROC) (“ROC” or the “Company”), a U.S. leader in multimodal Vision AI, building sovereign biometric, video analytics, and mission intelligence solutions into a unified platform, today announced the closing of its previously announced Initial Public Offering (the “Offering”) of 4,000,000 shares of common stock at a public offering price of $6.00 per share, which was the high end of the range, for total gross proceeds of $24 million, before deducting underwriting discounts and commissions and other Offering expenses. The Company intends to use the net proceeds from the Offering (i) to hire key resources that enable growth and support market share capture; (ii) to update and expand our neural-processing infrastructure to accelerate the pace in which we train and deploy Vision AI algorithms; and (iii) for working capital and general corporate purposes. In connection with the Offering, ROC has granted the underwriter a 30-day option to purchase up to an additional 600,000 shares of its common stock to cover over-allotments, if any.
By ROC · Via GlobeNewswire · February 23, 2026
Sana Biotechnology to Present at March 2026 Investor Conferences
SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in March. The presentations will feature a business overview and update.
By Sana Biotechnology, Inc · Via GlobeNewswire · February 23, 2026
NHI Announces Appointment of Lilly H. Donohue to the Board of Directors
MURFREESBORO, TN / ACCESS Newswire / February 23, 2026 / National Health Investors, Inc. (NYSE:NHI) announced today that Lilly H. Donohue has been appointed to the NHI Board of Directors effective February 17, 2026. Ms. Donohue's appointment follows an extensive search performed by a third party executive and board recruitment firm.
Via ACCESS Newswire · February 23, 2026
Twin Vee PowerCats Announces Closing of Public Offering
FORT PIERCE, FL / ACCESS Newswire / February 23, 2026 / Twin Vee PowerCats Co. (Nasdaq:VEEE), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced the closing of its public offering of 6,383,000 shares of common stock. Each share of common stock was sold at a public offering price of $0.47 per share, for gross proceeds of approximately $3 million, before deducting placement agent fees and other offering expenses.
Via ACCESS Newswire · February 23, 2026
Damon Announces Board Update
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2026) - Damon Inc. (OTC Pink: DMNIF) ("Damon" or the "Company"), a designer...
Via Newsfile · February 23, 2026
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of its Convertible Senior Notes due 2032 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Tandem also intends to grant the initial purchasers of the notes an option to purchase, within the 13-day period beginning on, and including, the first date on which the notes are issued, up to an additional $30.0 million principal amount of notes.
By Tandem Diabetes Care, Inc. · Via Business Wire · February 23, 2026
Citizens Financial Group to Participate at the 2026 RBC Capital Markets Financial Institutions Conference
Citizens Financial Group, Inc. (NYSE: CFG) announced today that President Brendan Coughlin and Chief Financial Officer Aunoy Banerjee will participate at the RBC Capital Markets Financial Institutions Conference to be held on Tuesday, March 10, 2026 at 11:20 am ET.
By Citizens Financial Group, Inc. · Via Business Wire · February 23, 2026
Octave Specialty Group Reports Fourth Quarter 2025 Results
Octave Specialty Group, Inc. (NYSE: OSG) ("Octave" or "OSG"), a global specialty insurance firm, today reported its results for the Fourth Quarter 2025.
By Octave Specialty Group, Inc. · Via Business Wire · February 23, 2026
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences:
By Acadia Pharmaceuticals Inc. · Via Business Wire · February 23, 2026
Yext to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on March 9, 2026
Yext, Inc. (NYSE: YEXT), the leading digital presence platform for multi-location brands, today announced that its fourth quarter and full fiscal year 2026 results will be released on Monday, March 9, 2026, after the close of the market.
By Yext, Inc. · Via Business Wire · February 23, 2026
Infinity Natural Resources Completes Transformational $1.2 Billion Acquisition of Ohio Utica Assets
Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) today announced the successful completion of its transformational $1.2 billion acquisition of upstream and midstream assets in the Ohio Utica Shale from Antero Resources Corporation and Antero Midstream Corporation (the “Transaction”). Announced on December 8, 2025, the Transaction represents INR's acquisition of an undivided 60% interest, increased from the originally announced 51% interest following the Company's previously announced $350 million strategic equity investment from Quantum Capital Group (“Quantum”) and Carnelian Energy Capital Management (“Carnelian”) that closed simultaneously with the Transaction. In addition to using proceeds from the strategic equity investment, the Transaction was funded through Infinity's existing credit facility and cash on hand, requiring no additional equity issuance.
By Infinity Natural Resources, Inc. · Via Business Wire · February 23, 2026
Box to Host Financial Analyst Day
Box, Inc. (NYSE:BOX), the leading Intelligent Content Management (ICM) platform, today announced that it will host its FY27 Financial Analyst Day on Thursday, March 19, 2026.
By Box, Inc. · Via Business Wire · February 23, 2026
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on clinical and operational progress for the fourth quarter and year ended December 31, 2025.
By Summit Therapeutics · Via Business Wire · February 23, 2026
JFrog to Present at Upcoming Investor Conferences
JFrog Ltd. (“JFrog”) (Nasdaq: FROG), the Liquid Software Company and creators of the JFrog Software Supply Chain Platform, today announced that it will present at the following investor conferences during the first quarter of 2026:
By JFrog Ltd. · Via Business Wire · February 23, 2026
ACV Announces Fourth Quarter and Full-Year 2025 Results
ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, today reported results for its fourth quarter and full-year ended December 31, 2025.
By ACV · Via Business Wire · February 23, 2026
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com.
By Hims & Hers · Via Business Wire · February 23, 2026
Keysight Technologies Reports First Quarter 2026 Results
Keysight Technologies, Inc. (NYSE: KEYS) today reported financial results for the first fiscal quarter ended January 31, 2026.
By Keysight Technologies, Inc. · Via Business Wire · February 23, 2026
Claritev Corporation Reports Fourth Quarter and Full Year 2025 Results
Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2025.
By Claritev Corporation · Via Business Wire · February 23, 2026
Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results
Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025.
By Addus HomeCare Corporation · Via Business Wire · February 23, 2026
Paymentus Reports Fourth Quarter and Full Year 2025 Financial Results
Paymentus Holdings, Inc. (“Paymentus”) (NYSE: PAY), a leading provider of cloud-based bill payment technology and solutions, today announced its unaudited financial results for its fourth quarter and full year ended December 31, 2025.
By Paymentus · Via Business Wire · February 23, 2026
Innovex Announces Fourth-Quarter and Full Year 2025 Results
Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the fourth quarter and full year 2025.
By Innovex Downhole Solutions, Inc. · Via Business Wire · February 23, 2026
Backblaze Announces Fourth Quarter and Full Year 2025 Financial Results
Backblaze, Inc. (Nasdaq: BLZE), the high-performance cloud storage platform for the AI era, today announced results for its fourth quarter ended December 31, 2025.
By Backblaze, Inc. · Via Business Wire · February 23, 2026
Gilead Sciences to Present at Upcoming Investor Conferences
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
By Gilead Sciences, Inc. · Via Business Wire · February 23, 2026
MediaAlpha Announces Fourth Quarter and Full Year 2025 Financial Results
Fourth Quarter Revenue of $291 million and Record Transaction Value of $613 million; Record Transaction Value of $552 million in Property & Casualty Insurance Vertical
By MediaAlpha, Inc. · Via GlobeNewswire · February 23, 2026
Olaplex Holdings, Inc. to Report Fourth Quarter and Fiscal 2025 Financial Results on March 5th
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report fourth quarter and fiscal 2025 financial results before the market opens on Thursday, March 5, 2026.
By Olaplex Holdings, Inc. · Via GlobeNewswire · February 23, 2026
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
Generated full-year 2025 net product sales of XDEMVY® of $451.4 million, an increase of more than 150% year-over-year
By Tarsus Pharmaceuticals, Inc · Via GlobeNewswire · February 23, 2026
EverQuote Announces Fourth Quarter and Full Year 2025 Financial Results
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced financial results for the fourth quarter and full year ended December 31, 2025.
By EverQuote, Inc. · Via GlobeNewswire · February 23, 2026
Adeia Announces Record Fourth Quarter and Full Year 2025 Financial Results
Achieved record revenue, operating income and adjusted EBITDA in the fourth quarter Signed long-term license agreement with Disney; two of the largest OTT providers now under licenseReduced debt by $60 million and repurchased $20 million of common stock in 2025
By Adeia Inc. · Via GlobeNewswire · February 23, 2026
Remitly Announces Upcoming Webinar and Investor Conference Participation
SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of financial services that transcend borders, today announced that its management team will present at the following investor conferences:
By Remitly, Inc. · Via GlobeNewswire · February 23, 2026
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
Highlights
By Myriad Genetics, Inc. · Via GlobeNewswire · February 23, 2026
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
Reported rinzimetostat (formerly ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors
By ORIC Pharmaceuticals · Via GlobeNewswire · February 23, 2026
Robinhood Markets, Inc. to Present at the Citizens Technology Conference on March 2, 2026
MENLO PARK, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Citizens Technology Conference on Monday, March 2, 2026.
By Robinhood Markets, Inc. · Via GlobeNewswire · February 23, 2026
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
EMERYVILLE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced that Jian Irish, Ph.D., M.B.A., President and Chief Executive Officer of the Company, will participate in a fireside chat at the 46th Annual TD Cowen Healthcare Conference, being held in Boston, MA, on Monday, March 2, 2026 at 11:10 a.m. ET.
By Metagenomi, Inc. · Via GlobeNewswire · February 23, 2026
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the fourth quarter and full year 2025 after the U.S. market close on Tuesday, March 24th, 2026. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.
By MaxCyte, Inc · Via GlobeNewswire · February 23, 2026
Phreesia Appoints Jon Kessler to Board of Directors
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the “Company”) today announced that it has appointed Jon Kessler to its Board, effective April 6, 2026. In addition, Edward L. Cahill and Michael Weintraub have informed the Board that they will retire from the Board, effective at the 2026 Annual Meeting.
By Phreesia, Inc. · Via Business Wire · February 23, 2026
PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that it has updated the timing of its previously announced fourth quarter 2025 earnings conference call and Investor Day due to significant travel disruptions caused by inclement weather.
By PROCEPT BioRobotics · Via GlobeNewswire · February 23, 2026
Hidden Operational Risks That Affect Service Based Businesses
Service based businesses operate within environments shaped by physical activity, customer interaction, and unpredictable conditions. While financial statements capture revenue and costs, they rarely reflect operational exposure tied to daily work conditions. Facilities, equipment, and human movement all influence stability, yet these factors often sit outside traditional market analysis until a disruption occurs.
Via AB Newswire · February 23, 2026
Amdocs to Speak at Morgan Stanley TMT Conference
JERSEY CITY, NJ / ACCESS Newswire / February 23, 2026 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced that CFO & COO Tamar Rapaport-Dagim will speak at the Morgan Stanley Technology, Media & Telecom Investor Conference on March 4 at 1:05 pm PT.
Via ACCESS Newswire · February 23, 2026
Letter to Shareholders From Marcus Lemonis, Executive Chairman and CEO: 2025 Year End Letter and 2026 Outlook
Bed Bath & Beyond, Inc. (NYSE: BBBY) (“Bed Bath & Beyond” or “BBBY”) has issued the following letter from Marcus Lemonis, Executive Chairman and Chief Executive Officer of Bed Bath & Beyond:
By Bed Bath & Beyond, Inc. · Via Business Wire · February 23, 2026
Super Group Reports Financial Results for Fourth Quarter and Full Year 2025
Super Group (SGHC) Limited (NYSE: SGHC) (“SGHC”, the "Company" or “Super Group”), the parent company of Betway, a leading online sports betting and gaming business, and Spin, the multi-brand online casino, today announced its fourth quarter and full year 2025 unaudited consolidated financial results.
By Super Group · Via Business Wire · February 23, 2026
Bed Bath & Beyond, Inc. Reports Eighth Consecutive Quarter of Measurable Improvement Toward Profitability
Bed Bath & Beyond, Inc. (NYSE:BBBY), owner of Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland’s Home and a blockchain asset portfolio, today reported financial results for the fourth quarter and full year ended December 31, 2025.
By Bed Bath & Beyond, Inc. · Via Business Wire · February 23, 2026
Forward Air Corporation Reports Fourth Quarter and Full Year 2025 Results
Forward Air Corporation (NASDAQ:FWRD) (the “Company”, “we”, “our”, or “us”) today reported financial results for the three months and twelve months ended December 31, 2025, as presented in the tables below.
By Forward Air Corporation · Via Business Wire · February 23, 2026
Xencor to Participate at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that company management will participate at multiple upcoming investor conferences:
By Xencor, Inc. · Via Business Wire · February 23, 2026